Nuzenio

Fda Grants Orphan

Fda Grants Orphan news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 7 latest news signals 7 publisher sources 100/100 entity strength

Latest news

FDA grants orphan drug status to potential treatment for ALL - Rare Cancer NewsRare Cancer News · Fri, 07 Aug 2026 18:08:50 GMTNieves Martinez Lago: FDA Grants Orphan Drug Designation to DLL3-Targeting ADC Zoci for NECs - OncodailyOncodaily · Fri, 07 Aug 2026 11:52:07 GMTFDA Names Zocilurtatug Pelitecan Orphan Drug in Neuroendocrine Carcinomas - Targeted OncologyTargeted Oncology · Wed, 05 Aug 2026 16:09:36 GMTFDA grants orphan drug designation to Zai Lab's zoci for neuroendocrine carcinomas - allsci.comallsci.com · Tue, 04 Aug 2026 12:20:33 GMTFDA Grants Orphan Drug Designation to Zocilurtatug Pelitecan for Neuroendocrine Carcinomas - OncLiveOncLive · Mon, 03 Aug 2026 15:59:22 GMTU.S. FDA Grants Orphan Drug Designation to Zai Lab’s DLL3-Targeting ADC Zocilurtatug Pelitecan (Zoci) for the Treatment of Neuroendocrine Carcinomas (NECs) - Business WireBusiness Wire · Mon, 03 Aug 2026 11:00:00 GMTFDA grants orphan drug status to experimental PAH treatment - Pulmonary Hypertension NewsPulmonary Hypertension News · Mon, 27 Jul 2026 19:49:48 GMT

Timeline

Fri, 07 Aug 2026 18:08:50 GMTFDA grants orphan drug status to potential treatment for ALL - Rare Cancer News
Fri, 07 Aug 2026 11:52:07 GMTNieves Martinez Lago: FDA Grants Orphan Drug Designation to DLL3-Targeting ADC Zoci for NECs - Oncodaily
Wed, 05 Aug 2026 16:09:36 GMTFDA Names Zocilurtatug Pelitecan Orphan Drug in Neuroendocrine Carcinomas - Targeted Oncology
Tue, 04 Aug 2026 12:20:33 GMTFDA grants orphan drug designation to Zai Lab's zoci for neuroendocrine carcinomas - allsci.com
Mon, 03 Aug 2026 15:59:22 GMTFDA Grants Orphan Drug Designation to Zocilurtatug Pelitecan for Neuroendocrine Carcinomas - OncLive
Mon, 03 Aug 2026 11:00:00 GMTU.S. FDA Grants Orphan Drug Designation to Zai Lab’s DLL3-Targeting ADC Zocilurtatug Pelitecan (Zoci) for the Treatment of Neuroendocrine Carcinomas (NECs) - Business Wire

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Fda Grants Orphan.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

7 distinct publisher/source names are currently connected to this entity page.